Cargando…
Use Pattern of Ophthalmic Antiglaucoma Agents with and without Preservatives: A Cross-Sectional Study
Background: Different drugs have been approved to reduce the intraocular pressure. However, most of them contain preservatives to maintain sterility and these can be toxic to the ocular surface. The aim was to determine the patterns of use of antiglaucoma agents and ophthalmic preservatives in a gro...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222872/ https://www.ncbi.nlm.nih.gov/pubmed/37242526 http://dx.doi.org/10.3390/ph16050743 |
_version_ | 1785049804501417984 |
---|---|
author | Valladales-Restrepo, Luis Fernando Oyuela-Gutiérrez, María Camila Delgado-Araujo, Ana Camila Machado-Alba, Jorge Enrique |
author_facet | Valladales-Restrepo, Luis Fernando Oyuela-Gutiérrez, María Camila Delgado-Araujo, Ana Camila Machado-Alba, Jorge Enrique |
author_sort | Valladales-Restrepo, Luis Fernando |
collection | PubMed |
description | Background: Different drugs have been approved to reduce the intraocular pressure. However, most of them contain preservatives to maintain sterility and these can be toxic to the ocular surface. The aim was to determine the patterns of use of antiglaucoma agents and ophthalmic preservatives in a group of patients from Colombia. Methods: A cross-sectional study that identified ophthalmic antiglaucoma agents from a population database of 9.2 million. Sociodemographic and pharmacological variables were considered. Descriptive and bivariate analyses were performed. Results: A total of 38,262 patients were identified, with a mean age of 69.2 ± 13.3 years, and 58.6% were women. A total of 98.8% were prescribed antiglaucoma drugs in multidose containers. The most widely used were prostaglandin analogs (59.9%), especially latanoprost (51.6%) and β-blockers (59.2%). A total of 54.7% of patients received combined management, especially with fixed-dose combination (FDC) drugs (41.3%). A total of 94.1% used antiglaucoma drugs with preservatives (benzalkonium chloride, 68.4%). Conclusions: The pharmacological treatment of glaucoma was very heterogeneous, but the most commonly used therapeutic groups were in accordance with the recommendations of clinical practice guidelines but with differences by sex and age. Most of the patients were exposed to preservatives, especially benzalkonium chloride, but the wide use of FDC drugs can minimize toxicity on the ocular surface. |
format | Online Article Text |
id | pubmed-10222872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102228722023-05-28 Use Pattern of Ophthalmic Antiglaucoma Agents with and without Preservatives: A Cross-Sectional Study Valladales-Restrepo, Luis Fernando Oyuela-Gutiérrez, María Camila Delgado-Araujo, Ana Camila Machado-Alba, Jorge Enrique Pharmaceuticals (Basel) Article Background: Different drugs have been approved to reduce the intraocular pressure. However, most of them contain preservatives to maintain sterility and these can be toxic to the ocular surface. The aim was to determine the patterns of use of antiglaucoma agents and ophthalmic preservatives in a group of patients from Colombia. Methods: A cross-sectional study that identified ophthalmic antiglaucoma agents from a population database of 9.2 million. Sociodemographic and pharmacological variables were considered. Descriptive and bivariate analyses were performed. Results: A total of 38,262 patients were identified, with a mean age of 69.2 ± 13.3 years, and 58.6% were women. A total of 98.8% were prescribed antiglaucoma drugs in multidose containers. The most widely used were prostaglandin analogs (59.9%), especially latanoprost (51.6%) and β-blockers (59.2%). A total of 54.7% of patients received combined management, especially with fixed-dose combination (FDC) drugs (41.3%). A total of 94.1% used antiglaucoma drugs with preservatives (benzalkonium chloride, 68.4%). Conclusions: The pharmacological treatment of glaucoma was very heterogeneous, but the most commonly used therapeutic groups were in accordance with the recommendations of clinical practice guidelines but with differences by sex and age. Most of the patients were exposed to preservatives, especially benzalkonium chloride, but the wide use of FDC drugs can minimize toxicity on the ocular surface. MDPI 2023-05-12 /pmc/articles/PMC10222872/ /pubmed/37242526 http://dx.doi.org/10.3390/ph16050743 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Valladales-Restrepo, Luis Fernando Oyuela-Gutiérrez, María Camila Delgado-Araujo, Ana Camila Machado-Alba, Jorge Enrique Use Pattern of Ophthalmic Antiglaucoma Agents with and without Preservatives: A Cross-Sectional Study |
title | Use Pattern of Ophthalmic Antiglaucoma Agents with and without Preservatives: A Cross-Sectional Study |
title_full | Use Pattern of Ophthalmic Antiglaucoma Agents with and without Preservatives: A Cross-Sectional Study |
title_fullStr | Use Pattern of Ophthalmic Antiglaucoma Agents with and without Preservatives: A Cross-Sectional Study |
title_full_unstemmed | Use Pattern of Ophthalmic Antiglaucoma Agents with and without Preservatives: A Cross-Sectional Study |
title_short | Use Pattern of Ophthalmic Antiglaucoma Agents with and without Preservatives: A Cross-Sectional Study |
title_sort | use pattern of ophthalmic antiglaucoma agents with and without preservatives: a cross-sectional study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222872/ https://www.ncbi.nlm.nih.gov/pubmed/37242526 http://dx.doi.org/10.3390/ph16050743 |
work_keys_str_mv | AT valladalesrestrepoluisfernando usepatternofophthalmicantiglaucomaagentswithandwithoutpreservativesacrosssectionalstudy AT oyuelagutierrezmariacamila usepatternofophthalmicantiglaucomaagentswithandwithoutpreservativesacrosssectionalstudy AT delgadoaraujoanacamila usepatternofophthalmicantiglaucomaagentswithandwithoutpreservativesacrosssectionalstudy AT machadoalbajorgeenrique usepatternofophthalmicantiglaucomaagentswithandwithoutpreservativesacrosssectionalstudy |